# Detailed DSD Clinical Background and Feature Cross-Reference Date: Tuesday 15 September 2026 Last Updated: Tuesday 15 September 2026 Type: Letter This is a patient-prepared detailed supporting record containing personal DSD-related clinical background and feature cross-reference material. It may be included with a referral if the GP considers it useful, but it is **not intended to replace the formal referral letter, original NHS records, clinical examination findings, laboratory results, imaging, or specialist assessment**. The GP does not need to read the whole document and may use, shorten, correct, reword, omit, or replace any part according to clinical relevance. ## Summary This is a patient-prepared detailed supporting record comparing documented or suspected personal features with the NHS / NHS England sources collected in the DSD reference source pool. Evidence labels used: - **A — Direct / objectively documented:** clinically recorded or formally measured. - **B — Plausible / requires clinical confirmation:** a personal concern or observation appears potentially relevant, but no formal clinical confirmation is available. - **C — Weak / nonspecific:** the observation may overlap with an official feature but is not specific enough to support DSD on its own. - **D — Not established:** current information is insufficient to say the feature is present. - **Unknown — clinically assessable / testable:** the feature cannot currently be classified from the available history and requires clinical assessment, testing, or clearer history. - **Context — referral circumstance:** relevant background or presentation context rather than diagnostic evidence. - **Testing pathway — specialist decision:** an NHS testing route that may become relevant if the clinical / biochemical picture supports it; not itself a personal feature. - **Support pathway — management / service context:** support or management that may become relevant after specialist assessment; not diagnostic evidence. - **Referral pathway — specialist destination decision:** service-navigation information rather than evidence for or against a diagnosis. This document does not diagnose DSD and does not claim eligibility for any specific genomic test. ## Background ### How this line of enquiry developed - The patient's original plan was to manage transition-related care independently and later use an overseas surgical service in Thailand. - The overseas pathway expected a period of HRT beforehand. At that stage, a sufficiently stable long-term medication supply was not available, which led the patient to explore UK hormone-care options. - While reviewing a Gender Identity Clinic (GIC) self-referral form, the patient noticed a reference to a **DSD condition** and began researching the term. - Further review of NHS / NHS England DSD, rare-disease and genomic material identified adult specialist DSD services at **Cambridge University Hospitals NHS Foundation Trust (CUH)** and **University College London Hospitals NHS Foundation Trust (UCLH)**. - Comparison with the patient's own developmental, anatomical and wider clinical history identified several areas of possible overlap that could not be reliably interpreted without specialist assessment. - The patient therefore decided not to treat the situation as a typical self-managed HRT pathway. - Although estradiol / Estrofem and Androcur are accessible to the patient, **none has ever been started or used**. This section records how the DSD question arose. It does not establish that a DSD condition is present. Primary reference: - **NHS DSD Reference Source Pool — Optional Background** Detailed personal records remain in their separate topic files and should be cross-referenced only where relevant. The purpose of this document is to identify which features may be worth presenting to a GP or specialist for clinical confirmation. ## Details ### 1. Core DSD overview and adult presentation #### 1.1 Micropenis Official reference: - NHS England GeNotes — Differences in sex development - NHS England GeNotes — Patient aged 18 with delayed puberty - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **B — Possible / requires clinical confirmation** Current personal information: - There is a personal concern that penile size may be smaller than expected and may possibly overlap with the clinical concept of micropenis. - No formal stretched penile length measurement has been performed. Interpretation: - This should remain a suspected developmental feature only. - If clinically relevant, formal stretched penile length measurement can be performed by a clinician. #### 1.2 Low testicular volume / small testes Official reference: - NHS England GeNotes — Patient aged 18 with delayed puberty - NHS — Klinefelter syndrome Current status: - **B — Possible / requires clinical confirmation** Current personal information: - There is a personal concern that testicular size may be smaller than expected. - No orchidometer measurement or ultrasound-based testicular volume has been recorded. Interpretation: - Testicular size cannot be reliably classified from visual estimation alone. - If clinically relevant, formal examination or measurement can establish whether testicular volume is reduced. #### 1.3 Possible abnormal testicular position Official reference: - NHS England GeNotes — Differences in sex development - NHS England GeNotes — Congenital hypogonadotropic hypogonadism - NHS — Androgen insensitivity syndrome Current status: - **B — Possible historical or current abnormal testicular position; requires clinical clarification** Current personal information: - The patient does not know the testicular position at birth. - There is a personal concern that testicular position may not always have been typical. - No childhood record, current examination, or imaging confirmation is presently available. Interpretation: - This should not be presented as confirmed cryptorchidism. - Congenital undescended testes, later ascending testes, retractile testes, and normal variation have not been distinguished. - If clinically relevant, examination and review of any available historical records can clarify this. #### 1.4 Hypospadias / chordee Official reference: - NHS England GeNotes — Differences in sex development - NHS — Androgen insensitivity syndrome Current status: - **D — Not established** Current personal information: - The patient is not currently able to identify whether hypospadias or chordee is present. Interpretation: - These are anatomical findings and should not be self-classified without a clear anatomical observation or clinical examination. - If clinically relevant, direct examination is the appropriate method of confirmation. #### 1.5 Failure to thrive Official reference: - NHS England GeNotes — Differences in sex development Current status: - **D — Not established** Current personal information: - No sufficiently specific childhood growth or weight record has yet been identified to establish failure to thrive. Interpretation: - This should remain unclaimed unless historical clinical records support it. #### 1.6 Hyponatraemia / dehydration Official reference: - NHS England GeNotes — Differences in sex development - NHS England GeNotes — Congenital adrenal hyperplasia Current status: - **D — Not established** Current personal information: - A separate July 2026 record documents marked thirst, increased urination, fatigue, salt preference and temporary use of oral rehydration solution. - These observations do **not** establish hyponatraemia or clinically diagnosed dehydration. Interpretation: - Do not convert salt preference, thirst or increased urination into an electrolyte diagnosis. - Laboratory results would be required to establish hyponatraemia. Cross-reference: - **July 2026 Excessive Thirst, Increased Urination and Salt Craving Record** #### 1.7 Atypical growth pattern / stature Official reference: - NHS England GeNotes — Differences in sex development - NHS — Klinefelter syndrome - NHS England GeNotes — Turner syndrome Current status: - **B — Previously clinically measured; exact values not currently available** Current personal information: - The patient recalls that a clinician previously measured arm span with both arms fully extended. - The patient recalls that arm span was greater than standing height. - Exact measurements and the clinician's formal interpretation are not currently available. Interpretation: - This is stronger than a purely visual self-observation because a clinical measurement was reportedly performed. - It should not be treated as a fully documented objective finding until the exact measurement or clinical record is available. #### 1.8 Gynaecomastia / breast tissue Official reference: - NHS England GeNotes — Differences in sex development - NHS — Klinefelter syndrome - NHS — Androgen insensitivity syndrome Current status: - **Unknown — clinically assessable** Current personal information: - There is a personal concern that breast tissue may be present. - No formal clinical assessment confirming gynaecomastia is currently recorded. Interpretation: - External appearance alone cannot reliably distinguish glandular tissue from fat. - Clinical inspection and palpation can assess whether gynaecomastia is present. #### 1.9 Infertility Official reference: - NHS England GeNotes — Differences in sex development - NHS — Klinefelter syndrome - NHS — Androgen insensitivity syndrome Current status: - **Unknown — testable** Current personal information: - There is no current objective fertility assessment establishing infertility. Interpretation: - Fertility should remain unknown unless supported by reproductive history, semen analysis or other clinical evidence. #### 1.10 Adult first presentation Official reference: - NHS — Differences in sex development - UCLH — Differences in Sex Development service Current status: - **Context — Relevant referral circumstance** Current information: - The present concern is being raised in adulthood without a previously established DSD diagnosis. Interpretation: - This is not evidence of a DSD diagnosis. - It is relevant because NHS and specialist-service information recognises that DSD may first be investigated in adolescence or adulthood. ### 2. Current NHS genomic testing routes #### 2.1 R146 — Differences in sex development Current status: - **Not an eligibility claim** Interpretation: - R146 should not be treated as a diagnosis or as proof that testing is required. - The purpose of the present cross-reference is to identify clinical features that may justify specialist assessment. - Whether R146 or any other genomic route is appropriate should be decided after clinical, chromosomal, biochemical and/or anatomical assessment as relevant. #### 2.2 R314 — Ambiguous genitalia Current status: - **Not established — requires professional anatomical assessment** Interpretation: - The present record does not establish that genital anatomy meets the clinical definition of ambiguous genitalia. - Possible penile-size or anatomical concerns should be examined clinically rather than self-classified as R314 eligibility. #### 2.3 R468 — Possible sex chromosome aneuploidy or structural rearrangement Current status: - **Not an eligibility claim** Interpretation: - This route becomes relevant when the clinical pattern creates suspicion of a sex-chromosome abnormality. - No sex-chromosome abnormality is presently established. ### 3. Puberty, hypogonadism and developmental features #### 3.1 Delayed, incomplete or absent puberty Official reference: - NHS England GeNotes — Patient aged 18 with delayed puberty - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **Unknown — historical pattern requires review** Current personal information: - The current historical record is not sufficiently clear to establish delayed, absent or arrested puberty. Interpretation: - This remains an important history question for a clinician and should remain unknown until the historical pattern is clarified. #### 3.2 LH / FSH and sex-hormone pattern Official reference: - NHS England GeNotes — Patient aged 18 with delayed puberty - NHS England GeNotes — Congenital hypogonadotropic hypogonadism - R148 Hypogonadotropic hypogonadism Current status: - **Unknown — laboratory assessment required** Current information: - No confirmed pattern of low testosterone / oestradiol with low or inappropriately normal LH / FSH is currently recorded here. Interpretation: - This is a laboratory question and should remain unknown unless clinical testing establishes a relevant pattern. #### 3.3 Anosmia / hyposmia Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **Unknown — subjective history unclear / formally assessable if relevant** Current personal information: - The patient cannot reliably determine whether sense of smell is reduced compared with normal. Interpretation: - Do not classify this as present or absent from self-comparison alone. - Formal assessment can be considered if clinically relevant. #### 3.4 Hypodontia / dental-development background Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **C — Possible developmental background; hypodontia not established** Current personal information: - Approximately 28 adult teeth are currently present. - There is a recollection that tooth replacement may not have been complete at around age 12. - Earlier drafts also noted uncertainty about eruption / arrangement. Interpretation: - Having 28 adult teeth does not by itself establish hypodontia. - The observation should be treated as dental-development background only unless dental records or examination confirm congenitally missing teeth or another developmental abnormality. #### 3.5 Joint flexibility / possible hypermobility background Reference context: - NHS — Joint hypermobility syndrome - Beighton-style joint hypermobility assessment references Current status: - **B — Previously clinically assessed; exact findings not currently available** Current personal information: - The patient recalls that a clinician previously assessed joint flexibility, including finger movement / backward extension. - The patient also recalls being asked about activities such as W-sitting. - The exact Beighton score, formal interpretation, and full examination findings are not currently available. Interpretation: - This should not be recorded as confirmed generalised joint hypermobility. - W-sitting is not itself a standard Beighton criterion. - If clinically relevant, a repeat standardised joint-hypermobility assessment can be performed. - This is adjacent musculoskeletal / developmental background rather than a core DSD feature. ### 4. Klinefelter syndrome — developmental and functional features #### 4.1 Developmental history Official reference: - NHS — Klinefelter syndrome Current status: - **C+ / possible historical supporting feature** Current personal information: - Independent walking was approximately **13 months**, which does not currently suggest a clear motor delay. - Family recalls that the patient **spoke very little before approximately age 3**. - No contemporaneous childhood developmental record is currently available. Interpretation: - The walking history does not currently add meaningful support. - The speech / language history may represent delayed speech development, but the exact milestone and degree of delay cannot be established retrospectively from family recall alone. - This should remain a supporting developmental history rather than a confirmed developmental diagnosis. #### 4.2 Reading / writing / spelling / attention difficulties Official reference: - NHS — Klinefelter syndrome - NHS — Dyslexia Current status: - **B/C — Present functional difficulty; formal diagnostic assessment incomplete** Current personal information: - The patient reports ongoing reading difficulty. - An ADHD assessment pathway has begun and a questionnaire has been received for completion. - Dyslexia has not been formally assessed and may be considered later, for example after returning to university. - Writing / spelling difficulty should only be added as a specific feature if the patient later confirms it clearly. Interpretation: - Reading difficulty is a current patient-reported functional problem. - Possible ADHD remains under assessment and is not yet a confirmed diagnosis. - Dyslexia should not be recorded as diagnosed. - These features are nonspecific and should only be used as supporting developmental context rather than as major DSD evidence. #### 4.3 Low energy Official reference: - NHS — Klinefelter syndrome Current status: - **C — Present as a symptom, but nonspecific** Current personal information: - The patient has a history of significant fatigue / low-energy episodes. - These episodes have occurred in the context of other health problems and are not specific to DSD. Interpretation: - Low energy is too nonspecific to carry substantial referral weight on its own. #### 4.4 Tall stature / long limbs / body proportions Official reference: - NHS — Klinefelter syndrome Current status: - **B — Previously clinically measured; exact values not currently available** Current personal information: - The patient recalls that a clinician measured arm span with both arms extended. - The patient recalls that arm span was greater than standing height. - Exact centimetre measurements and the clinician's formal interpretation are not currently available. Interpretation: - This is stronger than a purely visual self-observation because a clinical measurement was performed. - It should not yet be treated as a fully documented objective finding until the exact measurement or clinical record is available. #### 4.5 Broad hips Official reference: - NHS — Klinefelter syndrome Current status: - **C — Possible but nonspecific** Interpretation: - Broad hips may be visually apparent but are influenced by normal body-shape variation. - No formal clinical body-proportion assessment confirming this feature is currently available. - This should remain a minor supporting feature only. #### 4.6 Poor muscle tone / slower muscle growth Official reference: - NHS — Klinefelter syndrome Current status: - **B/C — Clinically relevant strength / functional background; mechanism not established** Current personal information: - Separate FCP / MSK records document lower-limb strength and functional difficulties, including previously recorded mild quadriceps weakness and continuing rehabilitation needs. Interpretation: - These records establish a genuine musculoskeletal / functional issue. - They do not establish that the problem represents Klinefelter-related poor muscle tone or reduced muscle development. - Detailed lower-limb history should remain in the dedicated MSK record. #### 4.7 Reduced facial / body hair Official reference: - NHS — Klinefelter syndrome Current status: - **C — Natural hair pattern cannot now be assessed reliably** Current personal information: - Regular shaving, grooming and IPL have altered the visible facial / body-hair pattern. Interpretation: - Current appearance should not be used to infer naturally reduced facial or body hair. - No clinical assessment confirming reduced hair growth is available. - This feature is unlikely to carry significant referral weight unless a clinician can establish a relevant historical or physical pattern. #### 4.8 Small, firm testes Official reference: - NHS — Klinefelter syndrome Current status: - **Small testes: B — Possible / requires clinical confirmation** - **Firm testes: D — Not established** Interpretation: - Possible reduced testicular size has already been recorded under the general DSD section. - Testicular volume can be assessed clinically using an orchidometer or ultrasound where relevant. - Testicular firmness / consistency requires clinical palpation and should not be self-classified. #### 4.9 Gynaecomastia Official reference: - NHS — Klinefelter syndrome Current status: - **Unknown — clinically assessable** Current personal information: - There is a personal concern about possible breast / chest tissue difference. - No clinical examination has established glandular breast tissue. Interpretation: - External appearance or cup size cannot reliably distinguish glandular tissue from fat. - Clinical examination, principally inspection and palpation, can assess whether gynaecomastia is present. - Further imaging is only required if clinically indicated. #### 4.10 Fertility status Official reference: - NHS — Klinefelter syndrome Current status: - **Unknown — testable** Interpretation: - Fertility cannot be inferred from appearance or from the current history. - If clinically relevant, assessment may include reproductive history, semen analysis and hormone testing. - Infertility should not be recorded as present unless clinically established. #### 4.11 Libido Official reference: - NHS — Klinefelter syndrome Current status: - **Unknown — subjective history unclear** Interpretation: - Libido is subjective and has many possible causes. - No single test establishes low libido. - If clinically relevant, a clinician can review sexual history alongside hormone status, medication, mood, sleep and general health. #### 4.12 Erectile function Official reference: - NHS — Klinefelter syndrome Current status: - **Unknown — history requires clarification** Interpretation: - Erectile difficulty generally refers to recurrent difficulty obtaining or maintaining an erection when desired. - The present record is not sufficiently clear to classify this as present or absent. - If relevant, this can be clarified through clinical history and assessment. ### 5. Androgen insensitivity syndrome (AIS / CAIS / PAIS) #### 5.1 Overall genital development Official reference: - NHS — Androgen insensitivity syndrome - NHS — Androgen insensitivity syndrome: diagnosis - UCLH — Complete androgen insensitivity syndrome (CAIS) Current status: - **Unknown — specialist anatomical assessment required** Current personal information: - The patient cannot reliably determine whether external genital development meets any clinical definition relevant to AIS / PAIS / CAIS. Interpretation: - External appearance alone should not be used to self-classify CAIS or PAIS. - If clinically relevant, specialist assessment may include physical examination, chromosome testing, hormone testing, genetic testing and imaging. #### 5.2 Undescended / partially undescended testes Official reference: - NHS — Androgen insensitivity syndrome Current status: - **B — Possible abnormal testicular position; requires clinical clarification** Interpretation: - This is the same feature already reviewed under the general DSD section. - The current record does not establish congenital undescended testes, ascending testes or retractile testes. - No separate AIS-specific rating is required. #### 5.3 Small / underdeveloped penis Official reference: - NHS — Androgen insensitivity syndrome Current status: - **B — Possible / requires clinical confirmation** Interpretation: - This overlaps with the earlier possible micropenis / reduced penile size concern. - Small penile size and formally defined micropenis should not be treated as identical without clinical measurement. - No separate AIS-specific rating is required. #### 5.4 Hypospadias Official reference: - NHS — Androgen insensitivity syndrome Current status: - **D — Not established** Current personal information: - The patient is not currently able to identify whether hypospadias is present. Interpretation: - This is an anatomical feature that can usually be assessed clinically. - It should remain unclaimed unless confirmed by a clear anatomical observation or clinical examination. #### 5.5 Pubic / underarm hair Official reference: - NHS — Androgen insensitivity syndrome - UCLH — Complete androgen insensitivity syndrome (CAIS) Current status: - **Unknown — difficult to assess retrospectively** Current personal information: - Regular grooming / hair removal means the natural pubic and underarm hair pattern is not currently easy to assess reliably. Interpretation: - Current visible hair distribution should not be used to infer an AIS-related pattern. - Historical information or clinical assessment can be considered if relevant. #### 5.6 Breast development Official reference: - NHS — Androgen insensitivity syndrome - UCLH — Complete androgen insensitivity syndrome (CAIS) Current status: - **Unknown — clinically assessable** Interpretation: - External appearance alone cannot reliably distinguish glandular breast tissue from fat. - Clinical inspection and palpation can assess breast / glandular tissue development if relevant. - Cup size should not be used as diagnostic evidence. #### 5.7 Puberty pattern Official reference: - NHS — Androgen insensitivity syndrome - UCLH — Complete androgen insensitivity syndrome (CAIS) Current status: - **Unknown — historical pattern requires specialist review** Interpretation: - The current personal puberty history is not sufficiently complete to classify an AIS-type pubertal pattern. - Specialist review may integrate pubertal history with hormone, chromosome and anatomical findings. #### 5.8 Gonadal / internal reproductive anatomy Official reference: - NHS — Androgen insensitivity syndrome: diagnosis - UCLH — Complete androgen insensitivity syndrome (CAIS) Current status: - **Unknown — investigation required** Interpretation: - Internal reproductive anatomy cannot generally be determined from external appearance. - If clinically indicated, assessment may include ultrasound or other imaging alongside chromosome and hormone testing. #### 5.9 Chromosome pattern Official reference: - NHS — Androgen insensitivity syndrome: diagnosis Current status: - **Unknown — testable** Interpretation: - AIS cannot be established from external appearance alone. - Chromosome analysis is one component of specialist diagnostic assessment. #### 5.10 Hormone / testosterone pattern Official reference: - NHS — Androgen insensitivity syndrome: diagnosis Current status: - **Unknown — laboratory assessment required** Interpretation: - AIS is not simply a condition of low testosterone; the central issue is altered androgen response. - Hormone results require specialist interpretation in the context of clinical and anatomical findings. #### 5.11 Androgen receptor genetic testing Official reference: - NHS — Androgen insensitivity syndrome: diagnosis Current status: - **Unknown — specialist / genetic testing decision** Interpretation: - Genetic testing may be considered where the clinical picture supports AIS. - The patient is not requesting a specific genetic test; the appropriate testing strategy should be determined clinically. #### 5.12 Fertility / sperm production Official reference: - NHS — Androgen insensitivity syndrome Current status: - **Unknown — testable** Interpretation: - Fertility and sperm production cannot be inferred from external appearance. - If clinically relevant, assessment may include semen analysis, hormone testing and gonadal assessment. ### 6. Congenital hypogonadotropic hypogonadism (CHH) / R148 #### 6.1 Micropenis Current status: - **Previously reviewed — B** Interpretation: - Retain the existing classification. - This feature has already been reviewed under the general DSD section and remains possible pending formal stretched penile length measurement. #### 6.2 Cryptorchidism / abnormal testicular position Current status: - **Previously reviewed — B** Interpretation: - Retain the existing classification. - Congenital undescended, ascending and retractile testes have not been distinguished clinically. #### 6.3 Delayed / absent / arrested puberty Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism - NHS England GeNotes — Patient aged 18 with delayed puberty Current status: - **Unknown — historical pattern requires review** Interpretation: - The available personal puberty history is not sufficiently complete to establish delayed, absent or arrested puberty. - Specialist review can integrate developmental history, physical findings and hormone results. #### 6.4 LH / FSH and sex-hormone pattern Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism - R148 Hypogonadotropic hypogonadism Current status: - **Unknown — laboratory assessment required** Interpretation: - This cannot be determined from appearance. - If clinically relevant, LH, FSH and sex-hormone testing can be interpreted in endocrine context. - The current document does not claim eligibility for R148. #### 6.5 Anosmia / hyposmia Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **Unknown — subjective history unclear / formally assessable if relevant** Current personal information: - The patient cannot reliably determine whether sense of smell is reduced compared with normal. Interpretation: - Do not classify anosmia or hyposmia as present. - Formal smell assessment can be considered if clinically relevant. #### 6.6 Hearing loss Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **D — No current evidence** Current personal information: - The patient reports no known hearing difficulty. - A previous aeromedical assessment was reportedly passed without difficulty. Interpretation: - No formal audiogram result is currently available in this working record. - This feature does not currently add support. #### 6.7 Mirror movements Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **D — Not established** Interpretation: - No current personal history or clinical finding supports mirror movements. - This feature should remain unclaimed unless identified on directed neurological examination or reliable history. #### 6.8 Midline abnormalities Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **D — Not established** Interpretation: - No known relevant midline developmental abnormality is currently recorded. - This feature does not currently add support. #### 6.9 Hypodontia / dental-development background Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **C — Relevant dental-development background; hypodontia not established** Current personal information: - Approximately **28 adult teeth are visibly present**. - The last four visible teeth appear to have erupted in positions similar to where wisdom teeth would normally be expected. - It is not known whether any further unerupted / impacted teeth are present, or whether any permanent teeth are congenitally absent. - There is also a recollection that tooth replacement may not have been complete at around age 12. Interpretation: - A visible count of 28 teeth does not establish hypodontia. - The eruption pattern and current visible tooth count are worth retaining as developmental background. - Dental records, professional examination and, if clinically relevant, dental imaging such as a panoramic radiograph would be required to determine whether hypodontia, impaction or another developmental dental pattern is present. #### 6.10 Renal agenesis Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **Unknown / not investigated** Interpretation: - Renal agenesis is generally not identifiable from external appearance. - No current personal history or imaging result establishes this feature. - It is currently a low-priority item unless other clinical findings make renal imaging relevant. #### 6.11 Congenital limb abnormalities Official reference: - NHS England GeNotes — Congenital hypogonadotropic hypogonadism Current status: - **D — No current evidence of a congenital limb abnormality** Current personal information: - Separate records document lower-limb pain, alignment observations, mild quadriceps weakness and functional difficulty. Interpretation: - These existing MSK findings do not establish a congenital limb abnormality. - The current musculoskeletal history should remain separate from this CHH-associated congenital feature. #### 6.12 R148 — Hypogonadotropic hypogonadism Current status: - **Testing pathway — only relevant if endocrine assessment supports hypogonadotropic hypogonadism** Interpretation: - R148 is not itself a clinical feature. - It becomes relevant when the clinical and biochemical picture supports hypogonadotropic hypogonadism, for example through pubertal history and an appropriate LH / FSH / sex-hormone pattern. - The current document does not claim eligibility for R148. ### 7. CAH / adrenal-related features #### 7.1 Salt-wasting crisis / electrolyte disturbance Official reference: - NHS England GeNotes — Congenital adrenal hyperplasia - NHS England GeNotes — Differences in sex development Current status: - **Hyponatraemia: D — Not established** - **Clinically confirmed dehydration: D — Not established** Current personal information: - A separate July 2026 record documents marked thirst, increased urination, fatigue, salt preference and temporary use of oral rehydration solution. Interpretation: - These symptoms do not establish hyponatraemia, hyperkalaemia, adrenal insufficiency or a salt-wasting crisis. - Typical classical salt-wasting CAH presentations depend on clinical and biochemical findings, often including electrolyte disturbance. - The July systemic episode should remain a separate background record unless laboratory evidence later supports an adrenal or electrolyte explanation. #### 7.2 Ambiguous genitalia / virilisation / under-virilisation Official reference: - NHS England GeNotes — Congenital adrenal hyperplasia - NHS England GeNotes — Differences in sex development Current status: - **Ambiguous genitalia: Not established — requires professional anatomical assessment** - **Hypospadias: Previously reviewed — D** - **Possible reduced penile size / micropenis: Previously reviewed — B** Interpretation: - Possible reduced penile size does not by itself establish a CAH-related genital phenotype. - Virilisation, under-virilisation and ambiguous genitalia are clinical anatomical concepts that should not be self-classified. - Clinical examination, chromosome context and biochemical assessment would be required if this direction becomes relevant. #### 7.3 Early puberty / androgen excess Official reference: - NHS England GeNotes — Congenital adrenal hyperplasia Current status: - **D — Not established** Interpretation: - No sufficiently clear history currently supports precocious puberty, markedly early pubic hair development, accelerated pre-pubertal growth, clinically significant androgen excess or advanced bone age. - This feature does not currently add support. #### 7.4 R180 — Congenital adrenal hyperplasia diagnostic test Current status: - **Testing pathway — only relevant if biochemical assessment supports CAH** Interpretation: - R180 is not itself a clinical feature. - The current NHS pathway relies on biochemical evidence of CAH together with the relevant clinical presentation. - The current document does not claim eligibility for R180. #### 7.5 R150 — Congenital adrenal hypoplasia Current status: - **Unknown / not established — requires endocrine evidence** Interpretation: - R150 is a testing pathway rather than a visible clinical feature. - Congenital adrenal hypoplasia requires evidence of adrenal insufficiency and exclusion of other relevant causes. - Current thirst, salt-preference or fatigue history does not establish adrenal insufficiency. - If clinically relevant, endocrine / biochemical assessment would determine whether this pathway has any relevance. #### 7.6 R160 — Primary pigmented nodular adrenocortical disease / ACTH-independent Cushing syndrome Current status: - **D — No current evidence supporting this pathway** Interpretation: - R160 is relevant where PPNAD or ACTH-independent Cushing syndrome has been clinically / biochemically established. - No current record establishes cortisol excess, ACTH-independent Cushing syndrome, PPNAD or a related adrenal lesion. - This pathway currently adds no referral support. #### 7.7 Rare CAH forms with under-virilisation Official reference: - NHS England GeNotes — Congenital adrenal hyperplasia Current status: - **Unknown — cannot be distinguished without endocrine assessment** Interpretation: - Some rarer CAH enzyme defects may involve androgen deficiency or under-virilisation rather than androgen excess. - Possible reduced penile size or other genital-development concerns do not identify a specific CAH subtype. - Hormone / adrenal steroid assessment and specialist interpretation would be required before this direction could be considered. #### 7.8 Hypertension / mineralocorticoid-excess patterns Official reference: - NHS England GeNotes — Congenital adrenal hyperplasia Current status: - **D — Not established** Interpretation: - No clear current history establishes early, persistent or otherwise unexplained hypertension associated with an adrenal steroid disorder. - This feature currently adds no support. ### 8. Turner syndrome, MRKH and lower-priority differential references #### 8.1 Turner syndrome Official reference: - NHS England GeNotes — Turner syndrome Current status: - **D / Low relevance on current information** Interpretation: - Typical Turner-related features include short stature, ovarian dysgenesis / primary ovarian insufficiency and absent or incomplete puberty. - The current record does not show a clear Turner-type pattern. - The reference remains useful for navigation but is unlikely to contribute materially to the GP referral case. #### 8.2 R468 — Possible sex chromosome aneuploidy or structural rearrangement Current status: - **Previously reviewed — testing pathway / specialist decision** Interpretation: - Retain the existing positioning. - R468 is relevant only if the overall clinical pattern creates suspicion of a sex-chromosome abnormality. #### 8.3 MRKH Official reference: - Imperial College Healthcare NHS Trust — MRKH Current status: - **D / Low relevance on current information** Interpretation: - MRKH is primarily defined by internal reproductive-tract anatomy, including uterine / cervical / vaginal development. - The current record does not show a clear MRKH-specific pattern. - This reference should remain in the navigation library but is unlikely to contribute to the final GP referral case unless new anatomical information emerges. #### 8.4 Primary ovarian insufficiency / R402 Current status: - **D / Not relevant on current information** Interpretation: - R402 relates to a specific ovarian-insufficiency pattern involving amenorrhoea and repeated FSH elevation. - No current information supports this pathway. - It should remain as a reference-library item only. #### 8.5 Renal, hearing and congenital skeletal associated findings Current status: - **Hearing: D — No current evidence** - **Renal anomaly: Unknown / not investigated, low priority** - **Congenital skeletal anomaly: D — No current evidence** Current personal information: - The patient reports no known hearing difficulty and previously passed an aeromedical assessment without difficulty. - No known renal developmental abnormality is currently recorded. - Existing lower-limb MSK problems do not establish a congenital skeletal anomaly. Interpretation: - These findings currently add little or no support to a DSD referral case. - Current musculoskeletal problems should remain separate from congenital skeletal-anomaly references unless a clinician identifies a specific developmental abnormality. ### 9. Bone health, HRT, gonadal management and referral support #### 9.1 Bone health / osteoporosis relevance Official reference: - UCLH — Complete androgen insensitivity syndrome (CAIS) - NHS — Osteoporosis: causes Current status: - **Unknown — bone disease not established; current MSK problem is separate relevant background** Current personal information: - Separate records document an ongoing lower-limb musculoskeletal / functional problem requiring FCP and MSK assessment and rehabilitation. Interpretation: - Current MSK symptoms do not establish osteoporosis, metabolic bone disease or hormone deficiency. - In some DSD / hypogonadal contexts, clinically significant sex-hormone deficiency may be relevant to long-term bone health. - If clinically indicated, bone-health assessment may include hormone status, vitamin / mineral assessment and bone-density testing. #### 9.2 HRT relevance Official reference: - UCLH — Complete androgen insensitivity syndrome (CAIS) - NHS — Androgen insensitivity syndrome - NHS — Osteoporosis: causes Current status: - **Unknown — depends on confirmed hormone / gonadal status** Current personal information: - The patient has access to estradiol / Estrofem and Androcur but has **never started or used these medicines**. - After considering possible DSD / endocrine questions, the patient chose not to start exogenous HRT before appropriate clinical assessment. Interpretation: - HRT is not being requested on the basis of current MSK symptoms alone. - If specialist assessment identifies clinically significant sex-hormone deficiency, loss of gonadal hormone function or another clear indication, hormone replacement may become relevant. - The patient does not have a preferred HRT regimen and is open to specialist guidance. #### 9.3 Gonadal surveillance / gonadectomy Official reference: - UCLH — Complete androgen insensitivity syndrome (CAIS) - UCLH — Laparoscopic gonadectomy - UCLH — Inguinal gonadectomy Current status: - **Unknown — diagnosis / gonadal anatomy dependent** Interpretation: - Gonadal surveillance, tumour-risk assessment or gonadectomy should not be assumed before a relevant DSD diagnosis or gonadal-anatomy finding is established. - If clinically indicated, specialist assessment may include examination, imaging, blood testing and multidisciplinary review. #### 9.4 Psychological / reproductive support Official reference: - NHS — Differences in sex development - UCLH — Differences in Sex Development service - UCLH — Women’s Health Psychological Services - UCLH — Reproductive Medicine Unit Current status: - **Support pathway — not diagnostic evidence** Interpretation: - Psychological, body-image, sexuality, relationship and reproductive support may form part of multidisciplinary DSD care where relevant. - These services are not evidence for or against a DSD diagnosis and do not require a separate personal feature classification. #### 9.5 UCLH / CUH referral navigation Official reference: - UCLH — Differences in Sex Development service - CUH — Adult disorders of sexual differentiation (DSD) clinic Current status: - **Referral pathway — specialist destination decision** Interpretation: - UCLH publicly describes a tertiary adolescent / adult DSD service and explicitly recognises adult first presentation. - CUH / Addenbrooke’s publicly lists an Adult DSD clinic within the Adult Endocrine service. - The patient is open to referral to either centre and does not require a specific destination. - As the patient is within the CUH area, Addenbrooke’s may be a practical local option, but another specialist centre such as UCLH is also acceptable if clinically or administratively more appropriate. - Public information does not clearly establish a complete comparison of the two services or all pre-referral requirements. - The GP may use local NHS referral pathways, service criteria, Advice and Guidance, or other appropriate referral mechanisms to determine the most suitable destination. #### 9.6 Broader clinical context Current status: - **Context — GP-level clinical consideration, not a DSD diagnostic claim** Interpretation: - Several different health problems have required assessment over a relatively short period. - These problems may ultimately be unrelated. - The patient would nevertheless appreciate the GP considering whether any broader underlying factor warrants assessment rather than treating every problem entirely in isolation. - This statement should not be used to imply that the current lower-limb, upper-limb, skin, systemic or other problems share a proven cause.